|
Symbol
|
RMACHV | ACKUTQ | ACLATQ | ACRFTQ | RMBDRV | RMBDNV | ADTRTQ | ADZYTQ | RMAV6V |
|---|---|---|---|---|---|---|---|---|---|
| Nom | Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Reverse Convertible | Reverse Convertible | Worst of Callable Reverse Convertible | Multi Reverse Convertible | Multi Vonti |
|
Sous-jacent
|
ASML Hldg. N.V. / Novo Nordisk AS (B) / SAP SE | Amgen Inc. / Intuitive Surgical Inc. / Novo Nordisk AS (B) | Amgen Inc. / Intuitive Surgical Inc. / Novo Nordisk AS (B) | Amgen Inc. / Intuitive Surgical Inc. / Novo Nordisk AS (B) | ASML Hldg. N.V. / Novo Nordisk AS (B) | ASML Hldg. N.V. / Novo Nordisk AS (B) | Adidas AG / LVMH Moet Hennessy Louis Vuitton / Novo Nordisk AS (B) | Alcon / Novo Nordisk AS (B) / Roche AG | ASML Hldg. N.V. / Novo Nordisk AS (B) / Oracle Corp. |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
17.08.2026 | 17.03.2027 | 17.03.2027 | 14.04.2027 | 13.08.2027 | 13.08.2027 | 20.08.2029 | 08.09.2026 | 11.10.2028 |
| Ratio | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
680,30 | 418,32 | 384,58 | 303,835 | 217,13 | 217,13 | 192,27 | 205,558 | 572,00 |
| rendement max. p.a. | 192,01% | 34,66% | 26,71% | 16,88% | 8,54% | 6,56% | 9,70% | 18,49% | 13,50% |
| Demande | 48,300 | 76,85 | 80,58 | 94,61 | 101,30 | 100,00 | 98,00 | 96,12 | 87,00 |
| Offre | 49,100 | 77,85 | 81,58 | 95,61 | 102,10 | 100,80 | 98,80 | 96,92 | 87,80 |